Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs

Experimental Hematology

Volumn 34, Issue 12, 2006, Pages 1759-1770

  Tillson, Michael ^a   Niemeyer, Glenn P ^a   Welch, Janet A ^a   Brawner, William ^a   Swaim, Steven F ^a   Rynders, Pat ^a   Lenz, Stephen D ^a   Dean, Bridget ^a   Lothrop Jr , Clinton D ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CREATININE; CYCLOSPORIN; DOG LEUKOCYTE ANTIGEN; LEUKOCYTE ANTIGEN; MICROSATELLITE DNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; BLOOD CELL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DNA DETERMINATION; DOG; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL TOXICITY; GRAFT REJECTION; GRAFT SURVIVAL; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; LYMPHOID CELL; MALE; NONHUMAN; NONMYELOABLATIVE CONDITIONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION DOSE; SKIN ALLOGRAFT; VOMITING; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DOGS; FEMALE; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; KIDNEY TRANSPLANTATION; MALE; SKIN TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

CANIS FAMILIARIS;

EID: 33751518329     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.08.004     Document Type: Article

References (41)

1. Storb R. Allogeneic hematopoietic stem cell transplantation-yesterday, today, and tomorrow. Exp Hematol 31 (2003) 1-10
2. Spitzer T.R. The expanding applications of non-myeloablative stem cell transplantation. Pediatr Transplant 7 (2003) 95-100
3. Wekerle T., and Sykes M. Mixed chimerism and transplantation tolerance. Annu Rev Med 52 (2001) 353-370
4. Field E.H., and Strober S. Tolerance, mixed chimerism and protection against graft-versus-host disease after total lymphoid irradiation. Phil Trans R Soc Lond 356 (2001) 739-748
5. Adler S.H., and Turka L.A. Immunotherapy as a means to induce transplantation tolerance. Curr Opin Immunol 14 (2002) 660-665
6. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3 (2003) 199
7. Storb R., Yu C., Wagner J.L., et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89 (1997) 3048-3054
8. Storb R., Yu C., Barnett T., et al. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood 94 (1999) 1131-1136
9. Sandmaier B.M., Fukuda T., Gooley T., Yu C., Santos E.B., and Storb R. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model. Exp Hematol 31 (2003) 168-175
10. Zaucha J.A., Yu C., Lothrop Jr. C.D., et al. Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation. Biol Blood Marrow Transplant 7 (2001) 14-24
11. Niemeyer G.P., Boudreaux M.K., Goodman-Martin S.A., Monroe C.M., Wilcox D.A., and Lothrop Jr. C.D. Correction of a large animal model of type 1 Glanzman's thrombasthemia by nonmyeloablative bone marrow transplantation. Exp Hematol 31 (2003) 1357-1362
12. Bauer Jr. T.R., Gu Y.C., Tuschong L.M., et al. Nonmyeloablative hematopoietic stem cell transplantation corrects the disease phenotype in the canine model of leukocyte adhesion deficiency. Exp Hematol 33 6 (2005) 706-712
13. Kuhr C.S., Allen M.D., Junghanss C., et al. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation 73 (2002) 1487-1492
14. McSweeney P.A., Niederwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97 (2001) 3390-3400
15. Kobbe G., Schneider P., Aivado M., et al. Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning. Exp Hematol 30 (2002) 1346-1353
16. Childs R., Chernoff A., Contentin N., et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 343 (2000) 750-758
17. Woolfrey A.E., Pulsipher M.A., and Storb R. Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children. Int J Hematol 76 (2002) 271-277
18. Niederwieser D., Maris M., Shizuru J.A., et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 101 4 (2003) 1620-1629
19. Niemeyer G.P., Welch J.A., Tillson M., et al. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil. Transplant Proc 37 (2005) 4579-4586
20. Wagner J.L., Burnett R.C., DeRose S.A., Francisco L.V., Storb R., and Ostrander E.A. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 62 (1996) 876-877
21. Niemeyer G.P., Hudson J., Bridgman R., Spano J., Nash R.A., and Lothrop C.D. Isolation and characterization of canine hematopoietic progenitor cells. Exp Hematol 29 (2001) 686-693
22. Stone E.A. Surgical therapy for urinary tract trauma. In: Stone E.A., et al. (Ed). Urological Surgery in the Dog and Cat (1992), WB Saunders, Philadelphia, PA
23. Yu C., Ostrander E., Bryant E., Burnett R., and Storb R. Use of (CA)n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 58 (1994) 701-706
24. Gianello P.R., Lorf T., Yamada K., et al. Induction of tolerance to renal allografts across single-haplotype MHC disparities in miniature swine. Transplantation 59 (1995) 884-890
25. Utsugi R., Barth R.N., Lee R.S., et al. Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine. Transplantation 71 (2001) 1368-1379
26. Hartner W.C., Markees T.G., DeFazio S.R., et al. Effect of early administration of donor bone marrow cells on renal allograft survival in dogs treated with antilymphocyte serum and cyclosporine. Transplantation 59 (1995) 131-155
27. Watanabe K., Ito K., Otani F., et al. Donor bone marrow cell infusion is effective in inducing tolerance in dogs treated with fractionated lymphoid irradiation and FK506. Transplant Proc 32 (2000) 2544-2547
28. Mathews K.A., Holmberg D.L., and Miller C.W. Kidney transplantation in dogs with naturally occurring end-stage renal disease. J Am Anim Hosp Assoc 36 (2000) 294-301
29. Finco D.R., Rawlings C.A., Crowell W.A., Brown S.A., and Barsanti J.A. Efficacy of azathioprine versus cyclosporine on kidney graft survival in transfused and nontransfused unmatched mongrel dogs. J Vet Intern Med 1 (1987) 61-66
30. Kyles A.E., Gregory C.R., Griffey S.M., Jackson J., Bernsteen L., and Morris R.E. An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs. Vet Surg 31 (2002) 358-366
31. Broaddus K.D., Tillson D.M., Lenz S.D., et al. Renal allograft histopathology in dog leukocyte antigen mismatched dogs after renal transplantation. Vet Surg 35 (2006) 125-135
32. Kawai T., Poncelet A., Sachs D.H., et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 68 (1999) 1767-1775
33. Kirk A.D., Harlan D.M., Armstrong N.N., et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 94 (1997) 8789-8794
34. Wekerle T., Kurtz J., Bigenzahn S., Takeuchi Y., and Sykes M. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 14 (2002) 592-600
35. Gleit Z.L., Fuchimoto Y., Yamada K., et al. Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning. Transplantation 74 (2002) 1535-1544
36. Umemura A., Morita H., Li X.C., Tahan S., Monaco A.P., and Maki T. Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation. J Immunol 167 (2001) 3043-3048
37. Zaucha J.M., Zellmer E., George G., et al. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required. Biol Blood Marow Transplant 7 11 (2001) 613-619
38. Tajik N., Singal D.P., Pourmand G., et al. Prospective study of microchimerism in renal allograft recipients: association between HLA-DR matching, microchimerism and acute rejection. Clin Transplant 15 (2001) 192-198
39. Light J., Salomon D.R., Diethelm A.G., et al. Bone marrow transfusions in cadaver renal allografts: pilot trials with concurrent controls. Clin Transplant 16 (2002) 317-324
40. Buhler L.H., Spitzer T.R., Sykes M., et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stange renal disease. Transplantation 74 (2002) 1405-1409
41. Millan M.T., Shizuru J.A., Hoffmann P., et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 73 (2002) 1386-1391